Opioid withdrawal: Difference between revisions
No edit summary |
|||
Line 2: | Line 2: | ||
{| class="infobox" style="float:right;" | {| class="infobox" style="float:right;" | ||
|- | |- | ||
| [[File:Siren.gif|30px|link=Opioid withdrawal resident survival guide]]|| <br> || <br> | |[[File:Siren.gif|30px|link=Opioid withdrawal resident survival guide]]||<br>||<br> | ||
| [[Opioid withdrawal resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | |[[Opioid withdrawal resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | ||
|} | |} | ||
{{Opioid}} | {{Opioid}} | ||
Line 12: | Line 12: | ||
==Historical Perspective== | ==Historical Perspective== | ||
* [[Opium]] and its derivatives have been used as medical therapies since 5,000 years ago.<ref name="pmid30701615">{{cite journal| author=Kosten TR, Baxter LE| title=Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | journal=Am J Addict | year= 2019 | volume= 28 | issue= 2 | pages= 55-62 | pmid=30701615 | doi=10.1111/ajad.12862 | pmc=6590307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30701615 }} </ref> | |||
* In the United States, in the early 20th century, [[opiates]] were [[over-the-counter]] drugs and were commonly used in [[medical therapy]] of various disorders.<ref name="pmid30701615">{{cite journal| author=Kosten TR, Baxter LE| title=Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | journal=Am J Addict | year= 2019 | volume= 28 | issue= 2 | pages= 55-62 | pmid=30701615 | doi=10.1111/ajad.12862 | pmc=6590307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30701615 }} </ref> | *[[Opium]] and its derivatives have been used as medical therapies since 5,000 years ago.<ref name="pmid30701615">{{cite journal| author=Kosten TR, Baxter LE| title=Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | journal=Am J Addict | year= 2019 | volume= 28 | issue= 2 | pages= 55-62 | pmid=30701615 | doi=10.1111/ajad.12862 | pmc=6590307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30701615 }} </ref> | ||
* In the early 1900s, the federal restrictions on [[opioid]] access caused suffering and death since there were no effective [[treatments]] for the [[opioid]] withdrawal symptoms that happened with sudden discontinuation of [[opioids]].<ref name="pmid30701615">{{cite journal| author=Kosten TR, Baxter LE| title=Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | journal=Am J Addict | year= 2019 | volume= 28 | issue= 2 | pages= 55-62 | pmid=30701615 | doi=10.1111/ajad.12862 | pmc=6590307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30701615 }} </ref> | *In the United States, in the early 20th century, [[opiates]] were [[over-the-counter]] drugs and were commonly used in [[medical therapy]] of various disorders.<ref name="pmid30701615">{{cite journal| author=Kosten TR, Baxter LE| title=Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | journal=Am J Addict | year= 2019 | volume= 28 | issue= 2 | pages= 55-62 | pmid=30701615 | doi=10.1111/ajad.12862 | pmc=6590307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30701615 }} </ref> | ||
*In the early 1900s, the federal restrictions on [[opioid]] access caused suffering and death since there were no effective [[treatments]] for the [[opioid]] withdrawal symptoms that happened with sudden discontinuation of [[opioids]].<ref name="pmid30701615">{{cite journal| author=Kosten TR, Baxter LE| title=Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | journal=Am J Addict | year= 2019 | volume= 28 | issue= 2 | pages= 55-62 | pmid=30701615 | doi=10.1111/ajad.12862 | pmc=6590307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30701615 }} </ref> | |||
==Classification== | ==Classification== | ||
The onset and duration of [[opioid]] withdrawal depends on the half-life of the consumed [[opioid]]: | |||
{| class="wikitable" | |||
|+ | |||
!Half-lives of Opioids | |||
!Onset of Withdrawal Symtoms | |||
!Duration of the syndrome | |||
|- | |||
|'''Short half-lives''' | |||
* eg, [[heroin]] at 3–5 h | |||
|Within 12 h of last use | |||
|eg, [[heroin]] withdrawal lasts 4–5 days | |||
|- | |||
|'''Long half-lives''' | |||
* eg, [[methadone]] at up to 96 h | |||
|1–3 days after last use | |||
| | |||
* [[Methadone]] withdrawal lasts 7–14 days | |||
* Some last for several weeks | |||
|} | |||
==Pathophysiology== | ==`Pathophysiology== | ||
==Causes== | ==Causes== | ||
[[Opioid]] withdrawal may be caused by discontinuation of repeated use of an [[opioid]].<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | [[Opioid]] withdrawal may be caused by discontinuation of repeated use of an [[opioid]].<ref name="DSMV">{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
==Differentiating opioid withdrawal from other diseases and conditions== | ==Differentiating opioid withdrawal from other diseases and conditions== | ||
[[Opioid]] withdrawal must be differentiated from:<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | [[Opioid]] withdrawal must be differentiated from:<ref name="DSMV">{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
*[[Benzodiazepines|Sedative-hypnotic withdrawal]] | *[[Benzodiazepines|Sedative-hypnotic withdrawal]] | ||
*[[Hallucinogen]] intoxication | *[[Hallucinogen]] intoxication | ||
*[[Stimulant]] intoxication | *[[Stimulant]] intoxication | ||
*[[Opioid]]-induced [[Clinical depression|depressive disorder]] | *[[Opioid]]-induced [[Clinical depression|depressive disorder]] | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Disease}} | ! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Disease}} | ||
! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Prominent clinical features}} | ! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Prominent clinical features}} | ||
! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Investigations}} | ! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Investigations}} | ||
|- | |- | ||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Hyperthyroidism}} | | colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Hyperthyroidism}} | ||
|The main symptoms include: | |The main symptoms include: | ||
* [[Palpitations]] | |||
* [[Insomnia]] | *[[Palpitations]] | ||
* [[Anxiety]] | *[[Insomnia]] | ||
* [[Weight loss]] | *[[Anxiety]] | ||
* Heat intolerance | *[[Weight loss]] | ||
* [[Diarrhea]] | *Heat intolerance | ||
* Depending on the underlying diagnosis, the patient might have [[exophthalmus]] or [[goiter]] | *[[Diarrhea]] | ||
*Depending on the underlying diagnosis, the patient might have [[exophthalmus]] or [[goiter]] | |||
| | | | ||
* The patient usually has elevated [[T3]] and [[T4]] | *The patient usually has elevated [[T3]] and [[T4]] | ||
* [[TSH]] might be increased or decreased depending on the underlying cause | *[[TSH]] might be increased or decreased depending on the underlying cause | ||
* [[TSI|Thyroid stimulating antibodies (TSI)]] might be increased in cases of [[Graves’ disease]] | *[[TSI|Thyroid stimulating antibodies (TSI)]] might be increased in cases of [[Graves’ disease]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Essential hypertension}} | | colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Essential hypertension}} | ||
|Most patients with hypertension are asymptomatic at the time of diagnosis. Common symptoms are listed below: | |Most patients with hypertension are asymptomatic at the time of diagnosis. Common symptoms are listed below: | ||
*[[Headache]] | *[[Headache]] | ||
*[[Blurry vision]] | *[[Blurry vision]] | ||
Line 68: | Line 91: | ||
*[[Creatinine]] or estimated [[GFR]] | *[[Creatinine]] or estimated [[GFR]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Generalized anxiety disorder}} | | colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Generalized anxiety disorder}} | ||
|According to DSM V, the following criteria should be present to fit the diagnosis of [[generalized anxiety disorder]]: | |According to DSM V, the following criteria should be present to fit the diagnosis of [[generalized anxiety disorder]]: | ||
Line 79: | Line 102: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|- | |- | ||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Menopause}} | | colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Menopause}} | ||
|The [[perimenopausal]] symptoms are caused by an overall drop, as well as dramatic but erratic fluctuations, in the levels of [[estrogens]], [[progestin]], and [[testosterone]]. Some of these symptoms such as [[formication]] etc may be associated with the hormone [[withdrawal]] process. | |The [[perimenopausal]] symptoms are caused by an overall drop, as well as dramatic but erratic fluctuations, in the levels of [[estrogens]], [[progestin]], and [[testosterone]]. Some of these symptoms such as [[formication]] etc may be associated with the hormone [[withdrawal]] process. | ||
Line 88: | Line 111: | ||
*Sexual disorders: [[Libido|decreased libido]], [[Vaginal lubrication|vaginal dryness]], problems reaching orgasm and [[dyspareunia]] | *Sexual disorders: [[Libido|decreased libido]], [[Vaginal lubrication|vaginal dryness]], problems reaching orgasm and [[dyspareunia]] | ||
| | | | ||
* [[Human chorionic gonadotropin|B-HCG]] should always be done first to rule out [[pregnancy]] especially in women under the age of 45 years | *[[Human chorionic gonadotropin|B-HCG]] should always be done first to rule out [[pregnancy]] especially in women under the age of 45 years | ||
* [[FSH]] can be measured but it can be falsely normal or low | *[[FSH]] can be measured but it can be falsely normal or low | ||
* [[TSH]], [[T3]] and [[T4]] to rule out thyroid abnormalities | *[[TSH]], [[T3]] and [[T4]] to rule out thyroid abnormalities | ||
* [[Prolactin]] can be measured to rule out [[prolactinoma]] as a cause of [[menopause]] | *[[Prolactin]] can be measured to rule out [[prolactinoma]] as a cause of [[menopause]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Opioid withdrawal disorder}} | | colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Opioid withdrawal disorder}} | ||
|According to DSM V, the following criteria should be present to fit the diagnosis of opioid withdrawal: | |According to DSM V, the following criteria should be present to fit the diagnosis of opioid withdrawal: | ||
# Cessation of (or reduction in) [[Opioid use disorders|opioid use]] that has been heavy and prolonged (i.e.,several weeks or longer) or administration of an [[opioid antagonist]] after a period of [[Opioid use disorders|opioid use]]. | |||
# Development of three or more of the following criteria minutes to days after cessation of drug use: [[Dysphoria|dysphoric mood]], [[nausea]] or [[vomiting]], [[muscle aches]], [[Lacrimation]] or [[rhinorrhea]], [[pupillary dilation]], [[piloerection]], or [[sweating]], [[diarrhea]], [[yawning]], [[fever]], and [[insomnia]]. | #Cessation of (or reduction in) [[Opioid use disorders|opioid use]] that has been heavy and prolonged (i.e.,several weeks or longer) or administration of an [[opioid antagonist]] after a period of [[Opioid use disorders|opioid use]]. | ||
# The signs or symptoms mentioned above must cause impairment of the daily functioning of the patient. | #Development of three or more of the following criteria minutes to days after cessation of drug use: [[Dysphoria|dysphoric mood]], [[nausea]] or [[vomiting]], [[muscle aches]], [[Lacrimation]] or [[rhinorrhea]], [[pupillary dilation]], [[piloerection]], or [[sweating]], [[diarrhea]], [[yawning]], [[fever]], and [[insomnia]]. | ||
# | #The signs or symptoms mentioned above must cause impairment of the daily functioning of the patient. | ||
#The signs or symptoms mentioned above must not be attributed to other medical or mental disorders. | |||
| | | | ||
* Urine drug screen to rule out any other associated drug abuse | *Urine drug screen to rule out any other associated drug abuse | ||
* Routine blood work such as electrolytes and hemoglobin to rule out any associated disease explaining the symptoms | *Routine blood work such as electrolytes and hemoglobin to rule out any associated disease explaining the symptoms | ||
|- | |- | ||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Pheochromocytoma}} | | colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Pheochromocytoma}} | ||
|The hallmark symptoms of a [[pheochromocytoma]] are those of [[sympathetic nervous system]] hyperactivity, symptoms usually subside in less than one hour and they may include: | |The hallmark symptoms of a [[pheochromocytoma]] are those of [[sympathetic nervous system]] hyperactivity, symptoms usually subside in less than one hour and they may include: | ||
*[[Palpitations]] especially in epinephrine producing tumors. | *[[Palpitations]] especially in epinephrine producing tumors. | ||
*[[Anxiety]] often resembling that of a [[panic attack]] | *[[Anxiety]] often resembling that of a [[panic attack]] | ||
Line 111: | Line 136: | ||
*Paroxysmal attacks of [[hypertension]] but some patients have normal blood pressure. | *Paroxysmal attacks of [[hypertension]] but some patients have normal blood pressure. | ||
*It may be asymptomatic and discovered by incidence screening especially [[MEN, type 2|MEN]] patients. | *It may be asymptomatic and discovered by incidence screening especially [[MEN, type 2|MEN]] patients. | ||
''Please note that not all patients with pheochromocytoma experience all classical symptoms''. | ''Please note that not all patients with pheochromocytoma experience all classical symptoms''. | ||
|Diagnostic lab findings associated with pheochromocytoma include: | |Diagnostic lab findings associated with pheochromocytoma include: | ||
*Elevated plasma and urinary [[catecholamine]]s and [[metanephrine]]s | *Elevated plasma and urinary [[catecholamine]]s and [[metanephrine]]s | ||
*Elevated urinary [[vanillyl mandelic acid]] | *Elevated urinary [[vanillyl mandelic acid]] | ||
Line 119: | Line 146: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The [[prevalence]] of [[opioid]] withdrawal is 6,000 per 100,000 (60%) of the population that have used [[heroin]] one or more time in the prior 12 months.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | The [[prevalence]] of [[opioid]] withdrawal is 6,000 per 100,000 (60%) of the population that have used [[heroin]] one or more time in the prior 12 months.<ref name="DSMV">{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
==Risk Factors== | ==Risk Factors== | ||
[[Opioid]] withdrawal may be caused by discontinuation of repeated use of an [[opioid]] in any setting such as:<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | [[Opioid]] withdrawal may be caused by discontinuation of repeated use of an [[opioid]] in any setting such as:<ref name="DSMV">{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
* [[Medical therapy]] of [[pain]] | |||
* [[Opioid]] agonist therapy for [[opioid use disorder]] | *[[Medical therapy]] of [[pain]] | ||
* [[Recreational]] use | *[[Opioid]] agonist therapy for [[opioid use disorder]] | ||
* Self-treating the symptoms of [[mental disorders]] | *[[Recreational]] use | ||
*Self-treating the symptoms of [[mental disorders]] | |||
==Screening== | ==Screening== | ||
Line 137: | Line 165: | ||
==Diagnosis== | ==Diagnosis== | ||
===Diagnostic Criteria=== | ===Diagnostic Criteria=== | ||
====DSM-V Diagnostic Criteria for Opioid Withdrawal<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>==== | ====DSM-V Diagnostic Criteria for Opioid Withdrawal<ref name="DSMV">{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>==== | ||
{{cquote| | {{cquote| | ||
*A. Presence of either of the following; | *A. Presence of either of the following; | ||
Line 167: | Line 195: | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
The most common [[symptoms]] of [[opioid]] withdrwal include :<ref name="pmid12924748">{{cite journal| author=Wesson DR, Ling W| title=The Clinical Opiate Withdrawal Scale (COWS). | journal=J Psychoactive Drugs | year= 2003 | volume= 35 | issue= 2 | pages= 253-9 | pmid=12924748 | doi=10.1080/02791072.2003.10400007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12924748 }} </ref><ref name="pmid27124502">{{cite journal| author=Vernon MK, Reinders S, Mannix S, Gullo K, Gorodetzky CW, Clinch T| title=Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification. | journal=Addict Behav | year= 2016 | volume= 60 | issue= | pages= 109-16 | pmid=27124502 | doi=10.1016/j.addbeh.2016.03.028 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27124502 }} </ref> | The most common [[symptoms]] of [[opioid]] withdrwal include :<ref name="pmid12924748">{{cite journal| author=Wesson DR, Ling W| title=The Clinical Opiate Withdrawal Scale (COWS). | journal=J Psychoactive Drugs | year= 2003 | volume= 35 | issue= 2 | pages= 253-9 | pmid=12924748 | doi=10.1080/02791072.2003.10400007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12924748 }} </ref><ref name="pmid27124502">{{cite journal| author=Vernon MK, Reinders S, Mannix S, Gullo K, Gorodetzky CW, Clinch T| title=Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification. | journal=Addict Behav | year= 2016 | volume= 60 | issue= | pages= 109-16 | pmid=27124502 | doi=10.1016/j.addbeh.2016.03.028 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27124502 }} </ref> | ||
* [[Anxiety]] | |||
* [[Anxiety]] | *[[Anxiety]] | ||
* [[Restlessness]] | *[[Anxiety]] | ||
* [[Irritability]] | *[[Restlessness]] | ||
* [[Insomnia]] | *[[Irritability]] | ||
* [[Hot flashes]] | *[[Insomnia]] | ||
* [[Chills]] | *[[Hot flashes]] | ||
* [[Sweating]] | *[[Chills]] | ||
* [[Pupillary dilatation]] | *[[Sweating]] | ||
* [[Heart]] pounding | *[[Pupillary dilatation]] | ||
* [[Lacrimation]] | *[[Heart]] pounding | ||
* [[Rhinorrhea]] | *[[Lacrimation]] | ||
* [[Yawning]] | *[[Rhinorrhea]] | ||
* Gooseflesh | *[[Yawning]] | ||
* [[Nausea, vomiting]] | *Gooseflesh | ||
* [[Abdominal]] cramps | *[[Nausea, vomiting]] | ||
* [[Diarrhea]] | *[[Abdominal]] cramps | ||
* [[Aches]], pain | *[[Diarrhea]] | ||
* Muscle [[spasms]], twitching | *[[Aches]], pain | ||
* [[Tremor]] | *Muscle [[spasms]], twitching | ||
*[[Tremor]] | |||
===Physical Examination=== | ===Physical Examination=== | ||
Common [[physical examination]] findings of [[opioid]] withdrwal include:<ref name="pmid12924748">{{cite journal| author=Wesson DR, Ling W| title=The Clinical Opiate Withdrawal Scale (COWS). | journal=J Psychoactive Drugs | year= 2003 | volume= 35 | issue= 2 | pages= 253-9 | pmid=12924748 | doi=10.1080/02791072.2003.10400007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12924748 }} </ref><ref name="pmid27124502">{{cite journal| author=Vernon MK, Reinders S, Mannix S, Gullo K, Gorodetzky CW, Clinch T| title=Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification. | journal=Addict Behav | year= 2016 | volume= 60 | issue= | pages= 109-16 | pmid=27124502 | doi=10.1016/j.addbeh.2016.03.028 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27124502 }} </ref><ref name="pmid30701615">{{cite journal| author=Kosten TR, Baxter LE| title=Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | journal=Am J Addict | year= 2019 | volume= 28 | issue= 2 | pages= 55-62 | pmid=30701615 | doi=10.1111/ajad.12862 | pmc=6590307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30701615 }} </ref> | Common [[physical examination]] findings of [[opioid]] withdrwal include:<ref name="pmid12924748">{{cite journal| author=Wesson DR, Ling W| title=The Clinical Opiate Withdrawal Scale (COWS). | journal=J Psychoactive Drugs | year= 2003 | volume= 35 | issue= 2 | pages= 253-9 | pmid=12924748 | doi=10.1080/02791072.2003.10400007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12924748 }} </ref><ref name="pmid27124502">{{cite journal| author=Vernon MK, Reinders S, Mannix S, Gullo K, Gorodetzky CW, Clinch T| title=Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification. | journal=Addict Behav | year= 2016 | volume= 60 | issue= | pages= 109-16 | pmid=27124502 | doi=10.1016/j.addbeh.2016.03.028 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27124502 }} </ref><ref name="pmid30701615">{{cite journal| author=Kosten TR, Baxter LE| title=Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | journal=Am J Addict | year= 2019 | volume= 28 | issue= 2 | pages= 55-62 | pmid=30701615 | doi=10.1111/ajad.12862 | pmc=6590307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30701615 }} </ref> | ||
* [[Anxiety]] | |||
* [[Restlessness]] | *[[Anxiety]] | ||
* [[Irritability]] | *[[Restlessness]] | ||
* [[Hypertension]] | *[[Irritability]] | ||
* [[Tachycardia]] | *[[Hypertension]] | ||
* [[Mydriasis]] | *[[Tachycardia]] | ||
* [[Piloerection]] (such as goose bumps) | *[[Mydriasis]] | ||
* [[Lacrimation]] | *[[Piloerection]] (such as goose bumps) | ||
* [[Rhinorrhea]] | *[[Lacrimation]] | ||
* [[Yawning]] | *[[Rhinorrhea]] | ||
* [[Nausea, vomiting]] | *[[Yawning]] | ||
* [[Diarrhea]] | *[[Nausea, vomiting]] | ||
* [[Sweating]] | *[[Diarrhea]] | ||
* Muscle [[spasms]], twitching | *[[Sweating]] | ||
* [[Tremor]] | *Muscle [[spasms]], twitching | ||
*[[Tremor]] | |||
===Laboratory Findings=== | ===Laboratory Findings=== |
Revision as of 12:00, 16 December 2020
Resident Survival Guide |
Opioid Microchapters |
Opioid withdrawal On the Web |
---|
American Roentgen Ray Society Images of Opioid withdrawal |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Overview
Opioid withdrawal occurs due to the cessation of opioids or the administration of an opioid antagonist following a heavy or prolonged use of opioids. Symptoms of withdrawal from opiates include, but are not limited to, depression, aggression and irritability, leg cramps, abdominal cramps, vomiting, diarrhea, insomnia, and cravings for the drug itself. Depending on the quantity, type, frequency, and duration of opioid use, the physical withdrawal symptoms last for as little as 5 days and as much as 14 days.
Historical Perspective
- Opium and its derivatives have been used as medical therapies since 5,000 years ago.[1]
- In the United States, in the early 20th century, opiates were over-the-counter drugs and were commonly used in medical therapy of various disorders.[1]
- In the early 1900s, the federal restrictions on opioid access caused suffering and death since there were no effective treatments for the opioid withdrawal symptoms that happened with sudden discontinuation of opioids.[1]
Classification
The onset and duration of opioid withdrawal depends on the half-life of the consumed opioid:
Half-lives of Opioids | Onset of Withdrawal Symtoms | Duration of the syndrome |
---|---|---|
Short half-lives
|
Within 12 h of last use | eg, heroin withdrawal lasts 4–5 days |
Long half-lives
|
1–3 days after last use |
|
`Pathophysiology
Causes
Opioid withdrawal may be caused by discontinuation of repeated use of an opioid.[2]
Differentiating opioid withdrawal from other diseases and conditions
Opioid withdrawal must be differentiated from:[2]
- Sedative-hypnotic withdrawal
- Hallucinogen intoxication
- Stimulant intoxication
- Opioid-induced depressive disorder
Disease | Prominent clinical features | Investigations |
---|---|---|
Hyperthyroidism | The main symptoms include:
|
|
Essential hypertension | Most patients with hypertension are asymptomatic at the time of diagnosis. Common symptoms are listed below: | JNC 7 recommends the following routine laboratory tests before initiation of therapy for hypertension:
|
Generalized anxiety disorder | According to DSM V, the following criteria should be present to fit the diagnosis of generalized anxiety disorder:
|
- |
Menopause | The perimenopausal symptoms are caused by an overall drop, as well as dramatic but erratic fluctuations, in the levels of estrogens, progestin, and testosterone. Some of these symptoms such as formication etc may be associated with the hormone withdrawal process.
|
|
Opioid withdrawal disorder | According to DSM V, the following criteria should be present to fit the diagnosis of opioid withdrawal:
|
|
Pheochromocytoma | The hallmark symptoms of a pheochromocytoma are those of sympathetic nervous system hyperactivity, symptoms usually subside in less than one hour and they may include:
Please note that not all patients with pheochromocytoma experience all classical symptoms. |
Diagnostic lab findings associated with pheochromocytoma include:
|
Epidemiology and Demographics
Prevalence
The prevalence of opioid withdrawal is 6,000 per 100,000 (60%) of the population that have used heroin one or more time in the prior 12 months.[2]
Risk Factors
Opioid withdrawal may be caused by discontinuation of repeated use of an opioid in any setting such as:[2]
- Medical therapy of pain
- Opioid agonist therapy for opioid use disorder
- Recreational use
- Self-treating the symptoms of mental disorders
Screening
Natural History, Complications and Prognosis
Depending on the quantity, type, frequency, and duration of opioid use, the physical withdrawal symptoms last for as little as 5 days and as much as 14 days. The user, upon returning to the environment where they usually used opiates, can experience environmentally implied physical withdrawal symptoms well-after regaining physical homeostasis - or the termination of the physical withdrawal phase by synthesis of endogenous opioids (endorphins) and upregulation of opioid receptors to the effects of normal levels of endogenous opioids. These implied symptoms are often just as distressing and painful as the initial withdrawal phase.
Detoxification is best conducted in an in patient facility that provides a controlled environment. Patients who are isolated and exposed solely to care givers and other patients in this environment have a better rate of staying clean then those who detox out-patient.
Diagnosis
Diagnostic Criteria
DSM-V Diagnostic Criteria for Opioid Withdrawal[2]
“ |
AND
AND
AND
|
” |
History and Symptoms
The most common symptoms of opioid withdrwal include :[3][4]
- Anxiety
- Anxiety
- Restlessness
- Irritability
- Insomnia
- Hot flashes
- Chills
- Sweating
- Pupillary dilatation
- Heart pounding
- Lacrimation
- Rhinorrhea
- Yawning
- Gooseflesh
- Nausea, vomiting
- Abdominal cramps
- Diarrhea
- Aches, pain
- Muscle spasms, twitching
- Tremor
Physical Examination
Common physical examination findings of opioid withdrwal include:[3][4][1]
- Anxiety
- Restlessness
- Irritability
- Hypertension
- Tachycardia
- Mydriasis
- Piloerection (such as goose bumps)
- Lacrimation
- Rhinorrhea
- Yawning
- Nausea, vomiting
- Diarrhea
- Sweating
- Muscle spasms, twitching
- Tremor
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography or Ultrasound
CT Scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Primary Prevention
References
- ↑ 1.0 1.1 1.2 1.3 Kosten TR, Baxter LE (2019). "Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment". Am J Addict. 28 (2): 55–62. doi:10.1111/ajad.12862. PMC 6590307 Check
|pmc=
value (help). PMID 30701615. - ↑ 2.0 2.1 2.2 2.3 2.4 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
- ↑ 3.0 3.1 Wesson DR, Ling W (2003). "The Clinical Opiate Withdrawal Scale (COWS)". J Psychoactive Drugs. 35 (2): 253–9. doi:10.1080/02791072.2003.10400007. PMID 12924748.
- ↑ 4.0 4.1 Vernon MK, Reinders S, Mannix S, Gullo K, Gorodetzky CW, Clinch T (2016). "Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification". Addict Behav. 60: 109–16. doi:10.1016/j.addbeh.2016.03.028. PMID 27124502.